ABSTRACT CATEGORIES - aacr.org

1 ABSTRACT CATEGORIES . The 2019 ABSTRACT CATEGORIES , along with their related subcategories and subclassifications, are given below. When you use the ABSTRACT Submission System, these options will be available for your selection. Please choose the appropriate category, subcategory, and subclassification that best describe the scientific content of the ABSTRACT and the particular scientific audience you wish to reach. This information will be utilized by the members of the Program Committee in their review of abstracts and planning of sessions at the Annual Meeting 2019.

2 Please note that these ABSTRACT CATEGORIES may or may not be used as Annual Meeting session titles. Before making your selection, please scan the entire list for the most appropriate ABSTRACT category, subcategory, and subclassification. MCB Molecular and MCB06 Cell Cycle TB Tumor Biology Gene expression in the microenvironment Cellular Biology, CDKs and CDK inhibitors Immune cells in the tumor Genetics Cell cycle checkpoints TB01 Non-Clinical Models of microenvironment Control of cell cycle progression Cancer Immunity and the microenvironment MCB01 Cell Growth Signaling Mitosis 3-D and tissue recombinant models Inflammatory cells as regulators of tumor Pathways Telomeres and telomerase Developmental phenotypes of cancer genes growth Cell signaling Other Human-in-mouse models of human cancer Microbiome Cell-cell interactions Model organisms in

3 Drug discovery Organ-specific microenvironments Growth factors MCB07 DNA Damage and Repair Mouse models of human cancer Proteases and inhibitors in the GTPases, their regulators, and effectors Chromosomal structural alterations/ Noninvasive imaging in animal models microenvironment Kinases and phosphatases translocations Zebrafish models of cancer Tumor dormancy Receptors Genomic instability Other animal and cell models of cancer Tumor/stromal interactions Tumor-stromal cell interactions Homologous recombination Other Tumor-immune system interactions Ubiquitin and ubiquitin-like proteins Mechanisms of genomic alterations Other Other Other TB02 Stem Cell Biology Adult stem cells

4 TB07 In Vivo Imaging MCB02 Cell Death MCB08 Metabolism and Cancer Cancer stem cells (See also CL01: Translational Apoptosis Metabolic pathways Developmental pathways in cancer Research Molecular Biology Autophagy Metabolomics Embryonic stem cells in the Clinic). Bcl-2 family proteins Mitochondrial function Stem cells and regenerative medicine Advanced nanotechnology and imaging Caspases Signaling pathways that regulate in oncology Application of imaging technology to the Effectors of apoptosis metabolism Stem cell markers clinic Inhibitors of apoptosis (IAP)

5 Family proteins Warburg effect Other Imaging in animal models Necrosis and necroptosis Other Imaging of molecular and cellular events Transcriptional control of apoptosis TB03 Tumor Adhesion in the tumor microenvironment Other MCB09 Genomics Cell adhesion and extracellular matrix Imaging of molecular and cellular events (See also BSB01: Cell-cell adhesion in tumors and tumor cells MCB03 Oncogenes and Tumor Bioinformatics and Drug resistance Imaging the immune response Suppressor Genes Computational Biology)

6 Other Imaging tumor metabolism Cytoplasmic signal transducers Functional genomics New targets for imaging Genotype/phenotype correlations Genomic profiling of tumors TB04 Invasion and Metastasis Other Nuclear oncoproteins and tumor High-throughput sequencing Actin cytoskeleton suppressor genes Large-scale approaches to cancer Biomarkers of metastasis TB08 Pediatric Cancer - Oncogene growth factors and their gene discovery Epithelial/mesenchymal transition Basic Science receptors Microarrays (EMT and MET) (See also CL02: Pediatric Tumor suppressor genes Other Expression profiling of tumor progression Cancer - Clinical Investigations.)

7 Other and metastasis CT04: Phase I, II, or III Clinical MCB10 microRNAs and Other Genes that regulate migration and invasion Trials in Pediatric Cancer). MCB04 Gene Regulation and Noncoding RNAs Imaging of tumor progression and Developmental signaling pathways in Transcription Factors Epigenetic control of miRNA expression metastasis childhood cancer Chromatin structure and function miRNA regulation of cancer biology Invasion and migration Epigenomics of childhood cancer Gene expression miRNA profiling in cancer Metastasis-promoting genes Non-clinical models of childhood cancer Mechanisms of transcription miRNA-based diagnostics Metastasis suppressor

8 Genes Pediatric cancer genomics Oncogenic transcription factors miRNA-based therapeutics Premetastatic niche Other Posttranscriptional and translational control miRNAs as tumor suppressors/oncogenes Therapeutic metastasis prevention Promoters and enhancers of transcription Noncoding RNAs Other TB09 Radiation Science Protein-protein interactions in Other (See also CL07: Radiation transcription factor function TB05 Angiogenesis Oncology; ET09: Preclinical Regulation of transcription factor function MCB11 Cellular Stress Responses Angiogenesis and angiogenesis inhibitors Radiotherapeutics).

9 Transcriptional control of cell differentiation Anoikis Host-tumor interactions DNA damage and repair and mutagenesis Other Hypoxia Molecular mechanisms of angiogenesis Molecular modulators of radiation response Oxidative stress Novel pro- and antiangiogenic factors Photobiology/photodynamic therapy MCB05 Epigenetics Senescence Tumor microcirculation and the Radiation carcinogenesis Chromatin structure and function Unfolded protein response microenvironment Radiation resistance DNA methylation Other VEGF/VEGF receptors Radiation-activated signaling pathways Epigenetic changes as molecular markers Other Radiation-induced gene expression of cancer Radioprotectors and radiosensitizers Epigenomics TB06 Tumor Microenvironment Other Gene silencing Chemokines in the microenvironment Histone modification Drug targets in the microenvironment Other Extracellular matrix and integrins Late-Breaking and Clinical Trials ABSTRACT Submission Deadline: January 10, 2019 27.

10 ABSTRACT CATEGORIES . TB10 Tumor Evolution and ET Experimental ET07 Biological Therapeutic CH03 Proteomics and Mass Heterogeneity and Molecular Agents Spectrometry Causes and consequences of tumor Therapeutics (See also CL06: Biological mass spectrometry and heterogeneity Immuno-oncology; IM02: systems biology Complex adaptive systems ET01 Drug Discovery Immunotherapy, Preclinical Proteomics and biomarker discovery Methods to measure tumor evolution Antibody technologies and Clinical) Proteomics and signaling networks and heterogeneity Biochemical modulators of the therapeutic Antireceptors Other Other index Apoptosis.